Suppr超能文献

在治疗大脑中动脉大型和巨大型部分血栓形成的动脉瘤时,使用纤溶药物逆转术中动脉血栓形成。

Reversal of intraoperative arterial thrombosis with a fibrinolytic agent when treating large and giant partially thrombosed aneurysms of the middle cerebral artery.

作者信息

Eliava Shalva, Pilipenko Yury, Shekhtman Oleg, Konovalov Anton

机构信息

Vascular (3rd) Department, Burdenko Neurosurgical Institute, Moscow, Russia.

出版信息

J Neurosurg. 2016 Apr;124(4):1114-22. doi: 10.3171/2015.2.JNS142655. Epub 2015 Oct 2.

Abstract

OBJECTIVE

Thrombosis of the cerebral arteries is one of the complications of microsurgical operations for partially thrombosed intracranial aneurysms. The object of this study was to assess the frequency of intraoperative arterial thrombosis (IAT) during microsurgical treatment of large and giant partially thrombosed aneurysms of the middle cerebral artery (MCA) and also to assess the efficacy of the treatment of this complication.

MATERIALS

The authors analyzed a consecutive series of 53 patients who underwent surgery for partially thrombosed aneurysms of the MCA at the Burdenko Neurosurgical Institute between January 2005 and September 2014. Thirty-two patients had large aneurysms (15-25 mm) and 21 had giant aneurysms (> 25 mm). Clipping of aneurysms was performed in 47 patients, trapping was performed in 3, and wrapping was performed in 3.

RESULTS

IAT was diagnosed in 10 patients (18.9%). The authors describe a technique for IAT reversal involving the injection of modified human recombinant prourokinase (mr-proUK). Of the 7 patients who underwent injection of mr-proUK in the thrombosed artery, 5 (71.4%) were discharged without any change in neurological status, 1 (14.3%) experienced moderate deterioration (modified Rankin Scale [mRS] score of 2), and 1 (14.3%) experienced severe deterioration (mRS score of 4). Among the 3 patients who had complications and did not receive an injection of mr-proUK, 2 experienced severe deterioration (mRS score of 3 and 4) and 1 had moderate deterioration (mRS score of 2).

CONCLUSIONS

The primary risk factor of thrombectomy with temporary trapping is thrombosis in the MCA branches. The injection of a fibrinolytic agent into thrombosed MCA branches is an effective method for the treatment of IAT.

摘要

目的

大脑动脉血栓形成是部分血栓形成的颅内动脉瘤显微手术的并发症之一。本研究的目的是评估大脑中动脉(MCA)大型和巨大型部分血栓形成动脉瘤显微手术期间术中动脉血栓形成(IAT)的发生率,并评估该并发症的治疗效果。

材料

作者分析了2005年1月至2014年9月期间在布尔坚科神经外科研究所接受MCA部分血栓形成动脉瘤手术的53例连续病例。32例为大型动脉瘤(15 - 25毫米),21例为巨大型动脉瘤(> 25毫米)。47例患者进行了动脉瘤夹闭,3例进行了包裹,3例进行了栓塞。

结果

10例患者(18.9%)被诊断为IAT。作者描述了一种IAT逆转技术,包括注射改良的人重组尿激酶原(mr - proUK)。在7例在血栓形成动脉中注射mr - proUK的患者中,5例(71.4%)出院时神经功能状态无变化,1例(14.3%)出现中度恶化(改良Rankin量表[mRS]评分为2),1例(14.3%)出现重度恶化(mRS评分为4)。在3例出现并发症且未注射mr - proUK的患者中,2例出现重度恶化(mRS评分为3和4),1例出现中度恶化(mRS评分为2)。

结论

临时栓塞取栓的主要危险因素是MCA分支血栓形成。向血栓形成的MCA分支注射纤溶药物是治疗IAT的有效方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验